The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes

Seminars in Neurology

Volumn 25, Issue 3, 2005, Pages 315-327

  Grindstaff, Paul ^a   Gruener, Gregory ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

HAM TSP; HTLV 1 infection; Myopathy; Neuromuscular; Neuropathy

Indexed keywords

METHOTREXATE; PREDNISONE; STEROID;

AIDS ASSOCIATED VACUOLAR MYELOPATHY; ANTERIOR HORN CELL DISEASE; ATAXIA; AUTOIMMUNE DISEASE; CEREBELLUM DISEASE; CLINICAL FEATURE; CRANIAL NEUROPATHY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; HTLV 1 ASSOCIATED MYELOPATHY TROPICAL SPASTIC PARAPARESIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HYPERREFLEXIA; LATHYRISM; MUSCLE DISEASE; MUSCLE WEAKNESS; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SPASTIC PARESIS; SPASTICITY; SPINAL CORD DISEASE; SYMPTOM; SYNDROME; THORACIC SPINAL CORD; TROPICAL ATAXIC NEUROPATHY; URINARY TRACT DISEASE;

HUMANS; PARAPARESIS, TROPICAL SPASTIC; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 26444568771     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-917668     Document Type: Review

References (78)

1. Montgomery RD, Cruickshank EK, Robertson WB, McMenemey WH. Clinical and pathological observations on Jamaican neuropathy. Brain 1964;87:425-462
2. Rodgers-Johnson P, Morgan OS, Mora C, et al. The role of HTLV-I in tropical spastic paraparesis in Jamaica. Ann Neurol 1988;23(suppl):S121-S126
3. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-410
4. Osame M, Usuku K, Izumo S, et al. HTLV-1 associated myelopathy, a new clinical entity [letter]. Lancet 1986;1: 1031-1032
5. Sugimura K, Takahashi A, Watanabe M, Mano K, Watanabe H. Demyelinating changes in sural nerve biopsy of patients with HTLV-I-associated myelopathy. Neurology 1990;40: 1263-1266
6. Roman GC. The neuroepidemiology of tropical spastic paresis. Ann Neurol 1988;23(suppl):S113-S120
7. Uchiyama T. Human T cell leukemia virus type I (HTLV-I). Annu Rev Immunol 1997;15:15-37
8. Nakagawa M, Izumo S, Ijichi S, et al. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995;1:50-61
9. Di Rocco A. HIV-associated myelopathy. Current Treatment Options in Infectious Diseases 2003;5:457-465
10. Zaninovic V. Similarities between tropical spastic paraparesis (TSP) and neurolathyrism. Lathyrus Lathyrism Newsletter 2001;2:11-14
11. Araújo A, Hall WW. Human T-lymphotropic virus type II and neurological disease. Ann Neurol 2004;56:10-19
12. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-1 (HTLV-1). J Emerg Med 2000;18:109-119
13. Simms I, Tosswill JHC, Noone A, Morgan D. Surveillance of HTLV infection in England and Wales: 1986-1992. Commun Dis Rep CDR Rev 1994;4:R65-R69
14. Vrielink H, Reesink HW. HTLVI/II prevalence in different geographic locations. Transfos Med Rev 2004;18:46-57
15. Vernant JC, Maurs L, Gessain A, et al. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type 1: a clinical and seroepidemiological study of 25 cases. Ann Neurol 1987;21:123-130
16. Araújo Ade Q, Afonso CR, Schor D, Leite AC, de Andrada-Serpa MJ. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/ TSP) in Rio de Janeiro, Brazil. Acta Neurol Scand 1993; 88:59-62
17. Bhigjee AI, Kelbe C, Haribhal HC, et al. Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in Natal, South Africa. Brain 1990;113:1307-1320
18. Tylleskär T, Banea M, Bikangi N, Cooke RD, Poulter NH, Rosling H. Cassava cyanogens and konzo, an upper motoneuron disease found in Africa. Lancet 1992;339:208-211
19. Ludolph AC, Spencer PS. Toxic models of upper motor neuron disease. J Neurol Sci 1996;139:53-59
20. Tylleskar T, Banea M, Bikangi N, Cooke RD, Poulter NH, Rosling H. Cassava cyanogens and konzo, an upper motoneuron disease found in Africa. Lancet 1992;339:208-211
21. Getahun H, Mekonnen A, TekleHaimanot R, Lambein F. Epidemic of neurolathyrism in Ethiopia. Lancet 1999;354: 306-307
22. Getahun H, Lambein F, Vanhoorne M, Van der Stuyft P. Pattern and associated factors of the neurolathyrism epidemic in Ethiopia. Trop Med Int Health 2002;7:118-124
23. Shasi Vardhan K, Pratap Rudra MP, Rao SL. Inhibition of tyrosine aminotransferase by β-N-oxalyl-L-a, β-diaminopropionic acid, the Lathyrus sativus neurotoxin. J Neurochem 1997;68:2477-2484
24. Oluwole OSA, Onabolu AO, Link H, Rosling H. Persistence of tropical ataxic neuropathy in a Nigerian community. J Neurol Neurosurg Psychiatry 2000;69:96-101
25. Oluwole OSA, Onabolu AO, Cotgreave IA, Rosling H, Persson A, Link H. Incidence of endemic ataxic polyneuropathy and its relation to exposure to cyanide in a Nigerian community. J Neurol Neurosurg Psychiatry 2003;74:1417-1422
26. Oluwole OSA, Onabolu AO, Link H, Rosling H. Persistence of tropical ataxic neuropathy in a Nigerian community. J Neurol Neurosurg Psychiatry 2000;69:96-101
27. Kaplan JE, Osama M, Kubota H, et al. The risk of development of HTLV-1-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990;3:1096-1101
28. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998;4:586-593
29. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-1 infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990;322:383-388
30. Toro C, Rodé B, Poveda E, Soriano V. Rapid development of subacute myelopathy in three organ transplant recipients after transplantation of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003;75:102-104
31. Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002;186(suppl 2):S187-S192
32. Imirizaldu JJ, Esteban JC, Axpe IR, et al. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry 2003;74:1080-1084
33. Izumo S, Goto I, Itoyama Y, et al. Interferon-alpha is effective in HTLV-I associated myelopathy: a multicenter, -double-blind, controlled trial. Neurology 1996;46:1016-1021
34. Alamy AH, Menezes FB, Leite AC, Nascimento OM, Araujo AQ. Dysautonomia in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 2001;50:681-685
35. Silva MTT, Mattos P, Alfano A, Araújo AQ-C. Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls. J Neurol Neurosurg Psychiatry 2003;74:1085-1089
36. Nakagawa M, Nakahara K, Maruyama Y, et al. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis. J Neurovirol 1996;2:345-355
37. Saito M, Nakagawa M, Kaseda S, et al. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-α therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2004;189:29-40
38. Silva MT, Araújo A. Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis. Arch Neurol 2004;61:1134-1135
39. Iwasaki Y. Human T cell leukemia virus type I infection and chronic myelopathy. Brain Pathol 1993;3:1-10
40. Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M. Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy. J Neurol 1999;246:358-364
41. Retroviruses. In: Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA, eds. Medical Microbiology. 4th ed. St. Louis: Mosby; 2002:574-590
42. Derse D, Heidecker G. Virology: forced entry-or does HTLV-1 have the key? [comments]. Science 2003;299:1670-1671
43. Hisada M, Stuver SO, Okayama A, et al. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis 2004;190:1605-1609
44. Hisada M, Maloney EM, Sawada T, et al. Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica. Clin Infect Dis 2002;34:1551-1557
45. Bangham CRM. Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control. Int J Hematol 2003;78:297-303
46. Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. Human T cell leukemia virus type I induced disease: pathways to cancer and neurodegeneration. Virology 2003;308:1-12
47. Brew BJ. The peripheral nerve complications of human immunodeficiency virus (HIV) infection. Muscle Nerve 2003; 28:542-552
48. Kiwaki T, Umehara F, Arimura Y, et al. The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy. J Neurol Sci 2003;206: 17-21
49. Arimura K, Arimura Y, Moritoyo H, et al. How helpful is thoracic paraspinal EMG in HAM/TSP? Muscle Nerve 1995;18:248-250
50. Corbin DO, Mora CA, Garriques S, Rodgers-Johnson P, Gibbs CJ. Anterior horn cell degeneration in polymyositis associated with human T lymphotropic virus type-1 in patients from Barbados. Am J Trop Med Hyg 1996;54:625-628
51. Ross MA, Miller RG, Berchert L, et al. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. Neurology 1998;50:768-772
52. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol 2000;6:544-548
53. Kuroda Y, Sugihara H. Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations. J Neurol Sci 1991;106:199-205
54. Vernant JC, Buisson G, Bellance R, Francois MA, Madkaud O, Zavaro O. Pseudo-amyotrophic lateral sclerosis, peripheral neuropathy and chronic polyradiculoneuritis in patients with HTLV-I-associated paraplegias. In: Roman G, Vernant JC, Osame M, eds. HTLV-1 and the Nervous System. New York: Alan R. Liss, Inc.; 1989:361-365
55. Evans BK, Gore I, Harrell LE, Arnold T, Oh SJ. HTLV-I-associated myelopathy and polymyositis in a US native. Neurology 1989;39:1572-1575
56. Arimura K, Nakashima H, Matsumoto W, et al. HTLV-I-associated myelopathy (HAM) presenting with ALS-like features. In: Roman G, Vernant JC, OsameM, eds. HTLV-1 and the Nervous System. New York: Alan R. Liss, Inc.; 1989: 367-370
57. Cruickshank JK, Rudge P, Dalgleish AG, et al. Tropical spastic paraparesis and human T cell lymphotropic virus type I in the United Kingdom. Brain 1989;112:1057-1090
58. Leite ACC, Silva MTT, Alamy AH, et al. Peripheral neuropathy in HTLV-1 infected individuals without tropical spastic paraparesis/HTLV-1-associated myelopathy. J Neurol 2004;251:877-881
59. Nascimento OJM, Araújo AQ, Freitas MRG, Escada TM, Andrad-Serpa MJ. Peripheral nerve involvement in HTLV-I associated myelopathy [abstract]. J Acquir Immune Defic Syndr 1995;10:230
60. Ludolph AC, Hugon J, Roman GC, Spencer PS, Schoenberg BS. A clinical neurophysiologic study of tropic spastic paraparesis. Muscle Nerve 1988;11:392-397
61. Barkhaus PE, Morgan O. Jamaican neuropathy: an electrophysiological study. Muscle Nerve 1988;11:380-385
62. Bhigjee AI, Bill PLA, Wiley CA, et al. Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP). Muscle Nerve 1993;16:21-26
63. Douen AG, Pringle CE, Guberman A. Human T-cell lymphotropic virus type-1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis. Arch Neurol 1997;54:896-900
64. Said G, Goulon-Goeau C, Lacroix C, Fève A, Descamps H, Fouchard M. Inflammatory lesions of peripheral nerve in a patient with human T-lymphotropic virus type I-associated myelopathy. Ann Neurol 1988;24:275-277
65. Nakazato O, Mori T, Okajima T. Sural nerve pathology in HTLV-I-associated myelopathy. In: Roman G, Vernant JC, Osame M, eds. HTLV-1 and the Nervous System. New York: Alan R. Liss, Inc.; 1989:269-274
66. Nakazato O, Mori T, Okajima T. Sural nerve pathology in HTLV-I associated myelopathy. Neurol Neurobiol 1989; 51:269-274
67. Littleton ET, Man WD, Holton JL, et al. Human T cell leukemia virus type 1 associated neuromuscular disease causing respiratory failure. J Neurol Neurosurg Psychiatry 2002;72:650-652
68. Cupler EJ, Leon-Monzon M, Miller J, et al. Inclusion body myositis in HIV and HTLV-1 infected patients. Brain 1996;119:1887-1893
69. Ozden S, Gessain A, Gout O, et al. Sporadic inclusion body myositis in a patient with human T-cell leukemia virus type-1 associated myelopathy. Clin Infect Dis 2001;32:510-514
70. Leon-Monzon M, Ilia I, Dalakas MC. Polymyositis in patients infected with human T-cell leukemia virus type 1: the role of the virus in the cause of the disease. Ann Neurol 1994;36:643-649
71. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989;2:1184-1187
72. Higuchi I, Nerenberg M, Yoshimine K, et al. Failure to detect HTLV-1 by in situ hybridization in the biopsied muscles of viral carriers with polymyositis. Muscle Nerve 1992;15:43-44
73. Nishikai M, Sato A. Human T lymphocyte virus type I and polymyositis and dermatomyositis in Japan [letter]. Arthritis Rheum 1991;34:791-792
74. Inose M, Higuchi I, Yoshimine K, et al. Pathological changes in skeletal muscle in HTLV-1 seropositive myelopathy. J Neurol Sci 1992;110:73-78
75. Smadja D, Bellance R, Cabre Ph, et al. Clinical characteristics of HTLV-1 associated dermato-polymyositis: seven cases from Martinique. Acta Neurol Scand 1995;92:206-212
76. Sowa JM. Human T lymphotropic virus I, myelopathy, polymyositis, and synovitis: an expanding rheumatic spectrum. J Rheumatol 1992;19:316-318
77. Gabbai AA, Wiley CA, Oliveira ASB, et al. Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy. Muscle Nerve 1994;17:923-930
78. Tarras S, Sheremata WA, Snodgrass S, Ayyar DR. Polymyositis and chronic myelopathy with presence of serum and cerebrospinal fluid antibody to HTLV-I. In: Roman G, Vernant JC, Osame M, eds. HTLV-1 and the Nervous System. New York: Alan R. Liss, Inc.; 1989:435-441